Pyridostigmine in Severe SARS-CoV-2 Infection
Clinical trial NCT04343963 · UNKNOWN
Trial details
- NCT number
- NCT04343963
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-04
- Primary completion
- 2020-09-30
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.